Strayer DS - Search Results

1

Progress and prospects: gene therapy clinical trials (part 2).

Aiuti A, Bachoud-Lévi AC, Blesch A, Brenner MK, Cattaneo F, Chiocca EA, Gao G, High KA, Leen AM, Lemoine NR, McNeish IA, Meneguzzi G, Peschanski M, Roncarolo MG, Strayer DS, Tuszynski MH, Waxman DJ, Wilson JM. Aiuti A, et al. Among authors: strayer ds. Gene Ther. 2007 Nov;14(22):1555-63. doi: 10.1038/sj.gt.3303033. Gene Ther. 2007. PMID: 17984995 Review.

2

Current status of gene therapy strategies to treat HIV/AIDS.

Strayer DS, Akkina R, Bunnell BA, Dropulic B, Planelles V, Pomerantz RJ, Rossi JJ, Zaia JA. Strayer DS, et al. Mol Ther. 2005 Jun;11(6):823-42. doi: 10.1016/j.ymthe.2005.01.020. Mol Ther. 2005. PMID: 15922953 Free article. Review.

3

HIV-1 proprotein processing as a target for gene therapy.

Cordelier P, Zern MA, Strayer DS. Cordelier P, et al. Among authors: strayer ds. Gene Ther. 2003 Mar;10(6):467-77. doi: 10.1038/sj.gt.3301891. Gene Ther. 2003. PMID: 12621451

4

Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.

Strayer DS, Pomerantz RJ, Yu M, Rosenzweig M, BouHamdan M, Yurasov S, Johnson RP, Goldstein H. Strayer DS, et al. Gene Ther. 2000 May;7(10):886-95. doi: 10.1038/sj.gt.3301159. Gene Ther. 2000. PMID: 10845727

5

Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.

Cordelier P, Van Bockstaele E, Calarota SA, Strayer DS. Cordelier P, et al. Among authors: strayer ds. Mol Ther. 2003 Jun;7(6):801-10. doi: 10.1016/s1525-0016(03)00093-5. Mol Ther. 2003. PMID: 12788654 Free article.

6

Factors influencing the production of recombinant SV40 vectors.

Vera M, Prieto J, Strayer DS, Fortes P. Vera M, et al. Among authors: strayer ds. Mol Ther. 2004 Oct;10(4):780-91. doi: 10.1016/j.ymthe.2004.06.1014. Mol Ther. 2004. PMID: 15451462 Free article.

7

What they are, how they work and why they do what they do? The story of SV40-derived gene therapy vectors and what they have to offer.

Strayer DS, Cordelier P, Kondo R, Liu B, Matskevich AA, McKee HJ, Nichols CN, Mitchell CB, Geverd DA, White MK, Strayer MS. Strayer DS, et al. Among authors: strayer ms. Curr Gene Ther. 2005 Apr;5(2):151-65. doi: 10.2174/1566523053544281. Curr Gene Ther. 2005. PMID: 15853724 Review.

8

SV40 mediates stable gene transfer in vivo.

Strayer DS, Milano J. Strayer DS, et al. Gene Ther. 1996 Jul;3(7):581-7. Gene Ther. 1996. PMID: 8818644

9

A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line.

Zern MA, Ozaki I, Duan L, Pomerantz R, Liu SL, Strayer DS. Zern MA, et al. Among authors: strayer ds. Gene Ther. 1999 Jan;6(1):114-20. doi: 10.1038/sj.gt.3300793. Gene Ther. 1999. PMID: 10341883

10

Intracisternal rSV40 administration provides effective pan-CNS transgene expression.

Louboutin JP, Reyes BA, Agrawal L, Van Bockstaele EJ, Strayer DS. Louboutin JP, et al. Among authors: strayer ds. Gene Ther. 2012 Jan;19(1):114-8. doi: 10.1038/gt.2011.75. Epub 2011 May 26. Gene Ther. 2012. PMID: 21614027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page